Tsumura & Co. is a high-risk pharmaceutical company based in Japan. Specializing in specialty and generic drug manufacturing, Tsumura generates revenue primarily from prescription Kampo products and over-the-counter medicines. Utilizing strategic collaborations and educational support at medical schools, the company aims to grow its operations in environment, sustainability, and governance. With an ESG score of 31.3, Tsumura is committed to expanding its research, development, manufacturing, and marketing capabilities.